Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Noncontrolling Interest
Beginning Balance at Dec. 31, 2022	$ 464,098	$ 14	$ 1,387,349	$ (4,116)	$ (919,082)	$ (67)
Beginning Balance, Shares at Dec. 31, 2022		143,105,002
Issuance of common stock for cash upon exercise of stock options	672		672
Issuance of common stock for cash upon exercise of stock options, Shares		145,758
Vesting of restricted stock units, net		1,029,209
Share-based compensation expense	14,671		14,671
Other comprehensive income (loss)	2,211			2,211
Net loss	(57,700)				(57,699)	(1)
Ending Balance at Mar. 31, 2023	423,952	$ 14	1,402,692	(1,905)	(976,781)	(68)
Ending Balance, Shares at Mar. 31, 2023		144,279,969
Beginning Balance at Dec. 31, 2023	308,278	$ 14	1,452,502	215	(1,144,332)	(121)
Beginning Balance, Shares at Dec. 31, 2023		145,082,271
Issuance of common stock for cash upon exercise of stock options	$ 44		44
Issuance of common stock for cash upon exercise of stock options, Shares	30,900	30,900
Vesting of restricted stock units, net		2,255,153
Share-based compensation expense	$ 14,298		14,298
Other comprehensive income (loss)	(321)			(321)
Net loss	(47,533)				(47,507)	(26)
Ending Balance at Mar. 31, 2024	$ 274,766	$ 14	$ 1,466,844	$ (106)	$ (1,191,839)	$ (147)
Ending Balance, Shares at Mar. 31, 2024		147,368,324